Craig Paterson
Keine laufenden Positionen mehr
Vermögen: 326 707 $ am 30.04.2024
Karriereverlauf von Craig Paterson
Ehemalige bekannte Positionen von Craig Paterson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALLAKOS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2021 | 09.02.2024 |
UMass Chan Medical School | Corporate Officer/Principal | - | - |
Vivelix Pharmaceuticalsc Corp. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Gründer | - | - | |
ENDO INTERNATIONAL PLC | Technik-/Wissenschafts-/F&E-Leiter | 08.09.2015 | - |
SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | - | - |
Ausbildung von Craig Paterson
McMaster University | Graduate Degree |
University of Tennessee | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Irland | 2 |
Kanada | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALLAKOS INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Vivelix Pharmaceuticalsc Corp. |
- Börse
- Insiders
- Craig Paterson
- Erfahrung